Evaluation of Exposures to Dust and Noise at a Pharmaceutical Manufacturing Facility
Public Domain
-
2023/10/01
File Language:
English
Details
-
Personal Author:
-
Corporate Authors:
-
Description:Management at a pharmaceutical manufacturing facility requested a health hazard evaluation of employees' exposures to pharmaceutical dust and noise during pharmaceutical manufacturing. During our visit to the facility, we observed work processes, work practices, and conditions
measured particulates in air during pharmaceutical manufacturing and packaging
took personal noise exposure measurements from workers involved in manufacturing and packaging pharmaceuticals
and measured sound levels throughout the manufacturing and packaging areas of the facility. We found that none of the average particle mass concentrations from the activities measured exceeded the OSHA PEL for total or respirable dust or ACGIH guidelines for respirable dust. However, particle concentrations reached these levels for short periods of time during tablet pressing when scooping powder by hand into the hopper. We recommend reducing airborne dust exposure as much as practicable by reducing or eliminating hand scooping of powder, reducing powder transport distance from containers to hoppers, eliminating use of compressed air to blow dust and powder off clothing, and minimizing use of compressed air to clean equipment. We also found that employees in the bottling room had the highest full-shift noise exposures. However, noise exposures did not exceed noise exposure limits. Noise in the bottling room and other areas where compressed air is used could potentially be reduced by using compressed air nozzles designed to produce less noise. We recommend continuing to use hearing protection during activities that generate sound levels above 85 dBA.
-
Subjects:
-
Keywords:
-
Source:Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, HHE 2021-0111-3391, 2023 Oct ; :1-32
-
Series:
-
DOI:
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:32 pdf pages
-
Contributor:Booher, Donald E. ; Hamilton, Cheryl ; Moore, Kevin ; Watts, Shawna
-
NIOSHTIC Number:nn:20068712
-
Citation:NIOSH [2023]. Evaluation of exposures to noise and dust at a pharmaceutical manufacturing ; facility. By Echt H, Brueck SE, O’Connor MC. Cincinnati, OH: U.S. Department of Health and ; Human Services, Centers for Disease Control and Prevention, National Institute for Occupational ; Safety and Health, Health Hazard Evaluation Report 2021-0111-3391,
-
Federal Fiscal Year:2024
-
NORA Priority Area:
-
Peer Reviewed:False
-
NAICS and SIC Codes:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:9c1944cbb494295b28931dfe7e8910a8011a827ff943cd8eb81b8a7d99b86774a80e4a691ec53779fc5d11a5c8f87af7054ecaedf2ac41c0338b3514ff6cd4e8
-
Download URL:
-
File Type:
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like